Regulatory Compliance

1. Overview

Factor EX Medical is committed to maintaining the highest standards of regulatory compliance, product quality, and safety. We work with cGMP manufacturing partners and adhere to all applicable federal, state, and local regulations governing the distribution and marketing of topical exosome products.

Our compliance program encompasses product quality assurance, regulatory adherence, ethical business standards, and transparent communication with healthcare providers.

2. Product Information

2.1 Product Description

Factor EX Medical distributes Wharton's Jelly-derived exosome products for professional use by licensed healthcare providers. Our products are available in two formulations:

• Factor EX Gold: 6 billion exosomes per vial
• Factor EX Silver: 3 billion exosomes per vial

2.2 Intended Use

Our products are intended for topical application by licensed healthcare professionals. Healthcare providers are responsible for using products within their scope of practice and in accordance with applicable regulations.

2.3 Source Material

Our exosome products are derived from Wharton's Jelly (umbilical cord tissue), a source of mesenchymal stromal cell-derived extracellular vesicles. All source material is obtained from ethical, consented donations and undergoes comprehensive screening and testing.

3. FDA Regulatory Framework

3.1 Regulatory Classification

Exosome products exist in a complex regulatory environment. Factor EX Medical works closely with cGMP manufacturing partners to ensure products are manufactured, tested, and distributed in accordance with applicable regulations.

3.2 Labeling and Marketing

We maintain conservative and evidence-based product labeling and marketing practices:

• No unapproved disease claims or drug-like representations
• Truthful and non-misleading product information
• Clear labeling of intended use
• Appropriate disclaimers and disclosures
• Professional education focused on science and mechanism of action

3.3 Compliance Monitoring

We continuously monitor regulatory developments affecting exosome products and update our practices accordingly to maintain compliance with evolving FDA guidance and regulations.

4. Manufacturing and Quality Assurance

4.1 Manufacturing Partners

Factor EX Medical works exclusively with manufacturing facilities that maintain current Good Manufacturing Practices (cGMP) and appropriate quality management systems.

4.2 Quality Control Testing

Each product lot undergoes comprehensive quality control testing, including:

• Endotoxin testing (USP <85>)
• Mycoplasma testing
• Particle size and concentration analysis
• Protein characterization and quantification
• Exosome marker verification (CD9, CD63, CD81)
• Stability testing

4.3 Certificate of Analysis

A Certificate of Analysis (CoA) is available for each product lot upon request, documenting:

• Lot number and manufacturing date
• Exosome concentration and purity
• Test results and specifications
• Quality release authorization
• Expiration date and storage conditions

5. Product Safety and Traceability

5.1 Lot Traceability

We maintain complete traceability for all product lots:

• Unique lot identification system
• Manufacturing records and batch documentation
• Testing records and quality control data
• Distribution records and chain of custody
• Customer delivery confirmation

5.2 Adverse Event Reporting

We maintain a comprehensive adverse event monitoring and reporting system. Healthcare providers must report any adverse reactions, product concerns, or quality issues to Factor EX Medical immediately.

Report adverse events: info@factorexmedical.com or (877) 735-7495

5.3 Product Recalls

In the event of a product safety concern, we have established procedures for rapid product recall and customer notification. Our traceability system enables swift identification and recovery of affected product lots.

6. Storage and Handling

6.1 Shelf-Stable Technology

Factor EX Medical products utilize advanced shelf-stable technology:

• No refrigeration required
• Room temperature storage (15-25°C / 59-77°F)
• Extended shelf life
• No reconstitution or mixing required
• Ready-to-use formulation

6.2 Storage Instructions

For optimal product stability and performance:

• Store at room temperature away from direct sunlight
• Keep in original packaging until ready to use
• Do not freeze
• Check expiration date before use
• Do not use if packaging is damaged or tampered with

7. Healthcare Provider Responsibilities

7.1 Professional Obligations

Healthcare providers using Factor EX Medical products are responsible for:

• Maintaining appropriate professional licenses and credentials
• Using products within their scope of practice
• Following standard of care guidelines
• Obtaining informed consent from patients
• Proper product storage, handling, and administration
• Accurate documentation and medical record-keeping
• Reporting adverse events and product concerns

7.2 Patient Safety

Healthcare providers must:

• Conduct appropriate patient screening and evaluation
• Assess contraindications and potential risks
• Provide patient education about procedures
• Monitor patients for adverse reactions
• Maintain professional liability insurance

8. Ethical Business Practices

8.1 Transparent Relationships

Factor EX Medical maintains ethical relationships with all stakeholders:

• Transparent pricing and business terms
• No hidden fees or misleading representations
• Clear communication of product capabilities and limitations
• Honest representation of scientific evidence
• Respect for healthcare provider autonomy and professional judgment

8.2 Anti-Kickback Compliance

We comply with federal and state anti-kickback statutes and do not offer illegal remuneration for product recommendations or purchases.

8.3 Marketing Practices

Our marketing and promotional activities adhere to ethical standards:

• Evidence-based product claims
• Appropriate substantiation for statements
• No misleading or exaggerated representations
• Professional education focused on mechanism of action
• Respect for regulatory boundaries

9. Training and Education

9.1 Provider Education

We provide healthcare providers with:

• Product information and technical specifications
• Scientific literature and research summaries
• Best practices for product use
• Safety and adverse event information
• Regulatory and compliance updates

9.2 Sales Representative Training

Our independent sales representatives receive training on:

• Product specifications and proper use
• Regulatory compliance and appropriate marketing
• Scientific evidence and mechanism of action
• Adverse event identification and reporting
• Ethical business practices

10. Continuous Improvement

10.1 Quality Monitoring

We continuously monitor product quality and customer feedback:

• Lot-to-lot consistency tracking
• Customer satisfaction monitoring
• Adverse event trend analysis
• Product complaint investigation
• Corrective and preventive action implementation

10.2 Regulatory Updates

We stay informed about regulatory developments and update our practices to maintain compliance with evolving FDA guidance and regulations affecting exosome products.

11. Contact Compliance Department

For compliance-related inquiries, product quality concerns, or to report adverse events, please contact:

12. Updates to Compliance Information

This compliance information is reviewed and updated regularly to reflect current regulations, industry standards, and best practices. Healthcare providers will be notified of material changes that may affect product use or regulatory status.